IDO1 and neoplasm: IDO1 contributes to tumor progression through immune suppression, tolerogenic APC induction, and MDSC-mediated effects, as detailed in the Mechanisms section (Munn and Mellor, 2013; Lewis-Ballester et al., 2016).